In-vitro毒性試験の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3249)
◆英語タイトル:Global In-vitro Toxicology Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3249
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、In-vitro毒性試験の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(細胞アッセイ、生化学的アッセイ、シリカ中、ex-vivo)、用途別市場規模(全身毒性、皮膚毒性、内分泌障害、眼毒性、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・In-vitro毒性試験の市場動向
・企業の競争状況、市場シェア
・In-vitro毒性試験の種類別市場規模(細胞アッセイ、生化学的アッセイ、シリカ中、ex-vivo)
・In-vitro毒性試験の用途別市場規模(全身毒性、皮膚毒性、内分泌障害、眼毒性、その他)
・In-vitro毒性試験の北米市場規模2016-2027(アメリカ、カナダ)
・In-vitro毒性試験の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・In-vitro毒性試験のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・In-vitro毒性試験の中南米市場規模2016-2027(メキシコ、ブラジル)
・In-vitro毒性試験の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Covance、GE Healthcare、Quest Diagnostics Inc.、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories、Catalent Pharma Solutions、Cyprotex、Agilent Technologies、Charles River Laboratories、Merck KgaA、Eurofins Scientific Inc.)
・結論
【レポートの概要】

In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells.
Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and high costs associated with conventional animal tests are poised to boost the inclination towards in-vitro toxicology assays.

Market Analysis and Insights: Global In-vitro Toxicology Testing Market
The global In-vitro Toxicology Testing market size is projected to reach US$ 16460 million by 2026, from US$ 10560 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Toxicology Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Toxicology Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Toxicology Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Toxicology Testing market.

Global In-vitro Toxicology Testing Scope and Market Size
In-vitro Toxicology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo

Segment by Application
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Covance
GE Healthcare
Quest Diagnostics Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Catalent Pharma Solutions
Cyprotex
Agilent Technologies
Quest Diagnostics Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Toxicology Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cellular Assay
1.2.3 Biochemical Assay
1.2.4 In Silica
1.2.5 Ex-vivo
1.3 Market by Application
1.3.1 Global In-vitro Toxicology Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Systemic Toxicology
1.3.3 Dermal Toxicity
1.3.4 Endorine Disruption
1.3.5 Occular Toxicity
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global In-vitro Toxicology Testing Market Perspective (2016-2027)
2.2 In-vitro Toxicology Testing Growth Trends by Regions
2.2.1 In-vitro Toxicology Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Toxicology Testing Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Toxicology Testing Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Toxicology Testing Industry Dynamic
2.3.1 In-vitro Toxicology Testing Market Trends
2.3.2 In-vitro Toxicology Testing Market Drivers
2.3.3 In-vitro Toxicology Testing Market Challenges
2.3.4 In-vitro Toxicology Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top In-vitro Toxicology Testing Players by Revenue
3.1.1 Global Top In-vitro Toxicology Testing Players by Revenue (2016-2021)
3.1.2 Global In-vitro Toxicology Testing Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Toxicology Testing Revenue
3.4 Global In-vitro Toxicology Testing Market Concentration Ratio
3.4.1 Global In-vitro Toxicology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicology Testing Revenue in 2020
3.5 In-vitro Toxicology Testing Key Players Head office and Area Served
3.6 Key Players In-vitro Toxicology Testing Product Solution and Service
3.7 Date of Enter into In-vitro Toxicology Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 In-vitro Toxicology Testing Breakdown Data by Type
4.1 Global In-vitro Toxicology Testing Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Toxicology Testing Forecasted Market Size by Type (2022-2027)

5 In-vitro Toxicology Testing Breakdown Data by Application
5.1 Global In-vitro Toxicology Testing Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Toxicology Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America In-vitro Toxicology Testing Market Size (2016-2027)
6.2 North America In-vitro Toxicology Testing Market Size by Type
6.2.1 North America In-vitro Toxicology Testing Market Size by Type (2016-2021)
6.2.2 North America In-vitro Toxicology Testing Market Size by Type (2022-2027)
6.2.3 North America In-vitro Toxicology Testing Market Size by Type (2016-2027)
6.3 North America In-vitro Toxicology Testing Market Size by Application
6.3.1 North America In-vitro Toxicology Testing Market Size by Application (2016-2021)
6.3.2 North America In-vitro Toxicology Testing Market Size by Application (2022-2027)
6.3.3 North America In-vitro Toxicology Testing Market Size by Application (2016-2027)
6.4 North America In-vitro Toxicology Testing Market Size by Country
6.4.1 North America In-vitro Toxicology Testing Market Size by Country (2016-2021)
6.4.2 North America In-vitro Toxicology Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe In-vitro Toxicology Testing Market Size (2016-2027)
7.2 Europe In-vitro Toxicology Testing Market Size by Type
7.2.1 Europe In-vitro Toxicology Testing Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Toxicology Testing Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Toxicology Testing Market Size by Type (2016-2027)
7.3 Europe In-vitro Toxicology Testing Market Size by Application
7.3.1 Europe In-vitro Toxicology Testing Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Toxicology Testing Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Toxicology Testing Market Size by Application (2016-2027)
7.4 Europe In-vitro Toxicology Testing Market Size by Country
7.4.1 Europe In-vitro Toxicology Testing Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Toxicology Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific In-vitro Toxicology Testing Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Toxicology Testing Market Size by Type
8.2.1 Asia-Pacific In-vitro Toxicology Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Toxicology Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Toxicology Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Toxicology Testing Market Size by Application
8.3.1 Asia-Pacific In-vitro Toxicology Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Toxicology Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Toxicology Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Toxicology Testing Market Size by Region
8.4.1 Asia-Pacific In-vitro Toxicology Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Toxicology Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America In-vitro Toxicology Testing Market Size (2016-2027)
9.2 Latin America In-vitro Toxicology Testing Market Size by Type
9.2.1 Latin America In-vitro Toxicology Testing Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Toxicology Testing Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Toxicology Testing Market Size by Type (2016-2027)
9.3 Latin America In-vitro Toxicology Testing Market Size by Application
9.3.1 Latin America In-vitro Toxicology Testing Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Toxicology Testing Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Toxicology Testing Market Size by Application (2016-2027)
9.4 Latin America In-vitro Toxicology Testing Market Size by Country
9.4.1 Latin America In-vitro Toxicology Testing Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Toxicology Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa In-vitro Toxicology Testing Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Toxicology Testing Market Size by Type
10.2.1 Middle East & Africa In-vitro Toxicology Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Toxicology Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Toxicology Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Toxicology Testing Market Size by Application
10.3.1 Middle East & Africa In-vitro Toxicology Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Toxicology Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Toxicology Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Toxicology Testing Market Size by Country
10.4.1 Middle East & Africa In-vitro Toxicology Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Toxicology Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott In-vitro Toxicology Testing Introduction
11.1.4 Abbott Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance In-vitro Toxicology Testing Introduction
11.2.4 Covance Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.2.5 Covance Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare In-vitro Toxicology Testing Introduction
11.3.4 GE Healthcare Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Quest Diagnostics Inc.
11.4.1 Quest Diagnostics Inc. Company Details
11.4.2 Quest Diagnostics Inc. Business Overview
11.4.3 Quest Diagnostics Inc. In-vitro Toxicology Testing Introduction
11.4.4 Quest Diagnostics Inc. Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.4.5 Quest Diagnostics Inc. Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Details
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories In-vitro Toxicology Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Catalent Pharma Solutions
11.7.1 Catalent Pharma Solutions Company Details
11.7.2 Catalent Pharma Solutions Business Overview
11.7.3 Catalent Pharma Solutions In-vitro Toxicology Testing Introduction
11.7.4 Catalent Pharma Solutions Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.7.5 Catalent Pharma Solutions Recent Development
11.8 Cyprotex
11.8.1 Cyprotex Company Details
11.8.2 Cyprotex Business Overview
11.8.3 Cyprotex In-vitro Toxicology Testing Introduction
11.8.4 Cyprotex Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.8.5 Cyprotex Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies In-vitro Toxicology Testing Introduction
11.9.4 Agilent Technologies Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.9.5 Agilent Technologies Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories In-vitro Toxicology Testing Introduction
11.10.4 Charles River Laboratories Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.10.5 Charles River Laboratories Recent Development
11.11 Merck KgaA
11.11.1 Merck KgaA Company Details
11.11.2 Merck KgaA Business Overview
11.11.3 Merck KgaA In-vitro Toxicology Testing Introduction
11.11.4 Merck KgaA Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.11.5 Merck KgaA Recent Development
11.12 Eurofins Scientific Inc.
11.12.1 Eurofins Scientific Inc. Company Details
11.12.2 Eurofins Scientific Inc. Business Overview
11.12.3 Eurofins Scientific Inc. In-vitro Toxicology Testing Introduction
11.12.4 Eurofins Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2016-2021)
11.12.5 Eurofins Scientific Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ In-vitro毒性試験の世界市場規模・現状・予測2021年-2027年(Global In-vitro Toxicology Testing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。